PG

Procter & Gamble Company
D

PG

Arincen73/100B

Procter & Gamble Company total debt 1986–2027

Procter & Gamble Company's total debt was 38.93B USD on 30 September 2026, up 8.3% on a year before. At the end of fiscal year 2026 it was 35.03B USD.

Last updated 5 Nov 2026 · Next report 21 Jan 2027

Total debt

Growth

Fiscal yearPeriod endingTotal debtGrowthCash and short-term investmentsNet cashDebt to equity
Latest quarter30 Sept 202638.93B+8.29%15.37B-23.56B0.71
FY202630 Jun 202635.03B-1.23%9.94B-25.08B0.64
FY202530 Jun 202535.46B+6.28%9.56B-25.91B0.68
FY202430 Jun 202433.37B-5.80%9.48B-23.89B0.66
FY202330 Jun 202335.42B+9.70%8.25B-27.18B0.76
FY202230 Jun 202232.29B-1.66%7.21B-25.08B0.69
FY202130 Jun 202132.84B-7.79%10.29B-22.55B0.71
FY202030 Jun 202035.61B+18.31%16.18B-19.43B0.77
FY201930 Jun 201930.10B-4.12%10.29B-19.81B0.64
FY201830 Jun 201831.39B-0.79%11.85B-19.54B0.60
FY201730 Jun 201731.64B+3.26%15.14B-16.51B0.57
FY201630 Jun 201630.64B+0.81%13.35B-17.30B0.53
FY201530 Jun 201530.40B-14.37%11.60B-18.79B0.49
FY201430 Jun 201435.50B+12.43%10.69B-24.81B0.51
FY201330 Jun 201331.57B+5.87%5.95B-25.63B0.46
FY201230 Jun 201229.82B-6.84%4.44B-25.39B0.47
FY201130 Jun 201132.01B+7.31%2.77B-29.25B0.47
FY201030 Jun 201029.83B-19.31%2.88B-26.95B0.49
FY200930 Jun 200936.97B+0.84%4.78B-32.19B0.59
FY200830 Jun 200836.67B+3.53%3.31B-33.35B0.53
FY200730 Jun 200735.41B-7.06%5.56B-29.86B0.53
FY200630 Jun 200638.10B+56.63%7.83B-30.28B0.61
FY200530 Jun 200524.33B+16.73%8.13B-16.20B1.32
FY200430 Jun 200420.84B+52.71%5.89B-14.95B1.21
FY200330 Jun 200313.65B-8.61%6.21B-7.44B0.84
FY200230 Jun 200214.93B+24.17%3.62B-11.31B1.09
FY200130 Jun 200112.03B-1.86%2.52B-9.51B1.00
FY200030 Jun 200012.25B+30.62%1.60B-10.65B1.00
FY199930 Jun 19999.38B+16.59%2.80B-6.58B0.78
FY199830 Jun 19988.05B+61.18%2.41B-5.64B0.66
FY199730 Jun 19974.99B-13.72%3.11B-1.88B0.41
FY199630 Jun 19965.79B-5.63%2.52B-3.27B0.49
FY199530 Jun 19956.13B-3.52%2.18B-3.95B0.58
FY199430 Jun 19946.36B-9.03%2.37B-3.98B0.72
FY199330 Jun 19936.99B-3.31%2.32B-4.66B0.94
FY199230 Jun 19927.23B+18.83%1.78B-5.45B0.80
FY199130 Jun 19916.08B+35.56%1.38B-4.70B0.79
FY199030 Jun 19904.49B+3.56%1.41B-3.08B0.60
FY198930 Jun 19894.33B+28.75%1.59B-2.74B0.83
FY198830 Jun 19883.36B+11.24%1.07B-2.30B0.53
FY198730 Jun 19873.02B-6.06%741.00M-2.28B0.53
FY198630 Jun 19863.22B—565.00M-2.65B0.56

Figures in USD at the end of each period. Net cash is cash and short-term investments less total debt; book value per share is on the diluted share count. The latest column is the most recent quarter.

Total debt counts commercial paper, term debt and lease liabilities.

See also:Revenue,Net income,EPS,Shares outstanding,Operating income,Cash on hand,Free cash flow,Stock buybacks,Balance sheet

Common questions about Procter & Gamble Company's debt

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.